Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chu-Pak Lau

Showing results (11-20 of 338) with videos related to

Pageof 34
Sort By:
JACC. Asia|June 16, 2023
Primary Prevention of Sudden Cardiac Death in AsiaChu-Pak Lau, Hung-Fat Tse
Drugs in R&D|April 30, 2003
Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiologyA John Camm, Chu-Pak Lau
Pacing and Clinical Electrophysiology : PACE|January 11, 2003
Bleeding and thromboembolic risks of internal cardioversion for persistent atrial fibrillationHung-Fat Tse, Chu-Pak Lau
Circulation|November 9, 2020
Letter by Lau and Tse Regarding Article, "Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study"Chu-Pak Lau, Hung-Fat Tse
Heart Rhythm|December 17, 2013
Response or nonresponse to cardiac resynchronization therapy in heart failure: lessons from the real worldChu-Pak Lau, Hung-Fat Tse
Journal of Cardiovascular Pharmacology and Therapeutics|June 15, 2007
Therapeutic angiogenesis with bone marrow--derived stem cellsHung-Fat Tse, Chu-Pak Lau
Cardiology Clinics|March 5, 2004
Future prospects for implantable devices for atrial defibrillationHung-Fat Tse, Chu-Pak Lau
Pacing and Clinical Electrophysiology : PACE|April 12, 2006
Primary prevention of heart failure in cardiac pacingS Serge Barold, Chu-Pak Lau
Journal of the American College of Cardiology|October 19, 2006
Selection of permanent ventricular pacing site: how far should we go?Hung-Fat Tse, Chu-Pak Lau
JACC. Clinical Electrophysiology|May 12, 2018
An Unpleasant Legacy: Infected Abandoned LeadsChu-Pak Lau, Hung-Fat Tse
Pageof 34

Showing results (11-20 of 338) with videos related to

Sort By:
Pageof 34
JACC. Asia|June 16, 2023
Primary Prevention of Sudden Cardiac Death in AsiaChu-Pak Lau, Hung-Fat Tse
Drugs in R&D|April 30, 2003
Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiologyA John Camm, Chu-Pak Lau
Pacing and Clinical Electrophysiology : PACE|January 11, 2003
Bleeding and thromboembolic risks of internal cardioversion for persistent atrial fibrillationHung-Fat Tse, Chu-Pak Lau
Circulation|November 9, 2020
Letter by Lau and Tse Regarding Article, "Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study"Chu-Pak Lau, Hung-Fat Tse
Heart Rhythm|December 17, 2013
Response or nonresponse to cardiac resynchronization therapy in heart failure: lessons from the real worldChu-Pak Lau, Hung-Fat Tse
Journal of Cardiovascular Pharmacology and Therapeutics|June 15, 2007
Therapeutic angiogenesis with bone marrow--derived stem cellsHung-Fat Tse, Chu-Pak Lau
Cardiology Clinics|March 5, 2004
Future prospects for implantable devices for atrial defibrillationHung-Fat Tse, Chu-Pak Lau
Pacing and Clinical Electrophysiology : PACE|April 12, 2006
Primary prevention of heart failure in cardiac pacingS Serge Barold, Chu-Pak Lau
Journal of the American College of Cardiology|October 19, 2006
Selection of permanent ventricular pacing site: how far should we go?Hung-Fat Tse, Chu-Pak Lau
JACC. Clinical Electrophysiology|May 12, 2018
An Unpleasant Legacy: Infected Abandoned LeadsChu-Pak Lau, Hung-Fat Tse
Pageof 34